Jifeng Wu

970 total citations
34 papers, 824 citations indexed

About

Jifeng Wu is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Jifeng Wu has authored 34 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in Jifeng Wu's work include Synthesis and Biological Evaluation (7 papers), Peptidase Inhibition and Analysis (6 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Jifeng Wu is often cited by papers focused on Synthesis and Biological Evaluation (7 papers), Peptidase Inhibition and Analysis (6 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Jifeng Wu collaborates with scholars based in China, United States and Germany. Jifeng Wu's co-authors include Xun Li, Hua Zhou, Leilei Shi, Yuemao Shen, Xun Li, Huaiyu Zhou, Wei Hu, Xun Li, Yong‐Tang Zheng and Wei Hu and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Gene.

In The Last Decade

Jifeng Wu

34 papers receiving 816 citations

Peers

Jifeng Wu
Sunita Bhagat India
Susan M. Pullen New Zealand
Yoshihiro Morinaga Japan
Darren McKerrecher United Kingdom
Takayuki Kudoh Japan
Seojeong Park South Korea
Yuanyuan An China
Ekaterina Yu. Rybalkina Russia
Shanhe Li China
Sunita Bhagat India
Jifeng Wu
Citations per year, relative to Jifeng Wu Jifeng Wu (= 1×) peers Sunita Bhagat

Countries citing papers authored by Jifeng Wu

Since Specialization
Citations

This map shows the geographic impact of Jifeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifeng Wu more than expected).

Fields of papers citing papers by Jifeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jifeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifeng Wu. The network helps show where Jifeng Wu may publish in the future.

Co-authorship network of co-authors of Jifeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jifeng Wu. A scholar is included among the top collaborators of Jifeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jifeng Wu. Jifeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jifeng, Yu Li, Miao Hu, et al.. (2025). Gas–Proton Microenvironment Modulation for Enhanced CO 2 ‐to‐Formate Electroreduction. Angewandte Chemie International Edition. 65(1). e202516163–e202516163. 1 indexed citations
2.
Liu, Yang, Qiuju Liu, Jianfei Fu, et al.. (2024). Polyfluorinated Organic Diammonium Induced Lead Iodide Arrangement for Efficient Two‐Step‐Processed Perovskite Solar Cells. Angewandte Chemie International Edition. 63(26). e202402568–e202402568. 21 indexed citations
3.
4.
Liu, Yang, Qiuju Liu, Jianfei Fu, et al.. (2024). Polyfluorinated Organic Diammonium Induced Lead Iodide Arrangement for Efficient Two‐Step‐Processed Perovskite Solar Cells. Angewandte Chemie. 136(26). 7 indexed citations
5.
Xi, Yanfeng, Chen Xu, Yiqiang Liu, et al.. (2020). The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer. Pathology - Research and Practice. 216(4). 152882–152882. 3 indexed citations
6.
Wu, Jifeng, et al.. (2019). <p>The safety and efficacy of amrubicin in the treatment of previously untreated extensive-disease small-cell lung cancer: a meta-analysis</p>. OncoTargets and Therapy. Volume 12. 5135–5142. 1 indexed citations
7.
Hu, Wei, Xusheng Huang, Jifeng Wu, et al.. (2018). Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches. Journal of Medicinal Chemistry. 61(20). 8947–8980. 99 indexed citations
8.
Shi, Leilei, Jianfeng Zhou, Jifeng Wu, et al.. (2016). Quinoxalinone (Part II). Discovery of (Z)-3-(2-(pyridin-4-yl)vinyl)quinoxalinone derivates as potent VEGFR-2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 24(8). 1840–1852. 38 indexed citations
9.
Hu, Wei, Chen Li, Jifeng Wu, et al.. (2016). Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469. European Journal of Medicinal Chemistry. 124. 311–325. 31 indexed citations
10.
Shi, Leilei, Jianfeng Zhou, Jifeng Wu, Yuemao Shen, & Xun Li. (2016). Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect. Current Medicinal Chemistry. 23(10). 1000–1040. 26 indexed citations
11.
Yang, Liang, Ping Wang, Jifeng Wu, et al.. (2016). Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors. Bioorganic & Medicinal Chemistry. 24(9). 2125–2136. 46 indexed citations
12.
McKay, Rana R., Katherine Zukotynski, Lillian Werner, et al.. (2014). Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17(4). 325–331. 28 indexed citations
13.
Sun, Ruochuan, Jifeng Wu, Yuanyuan Chen, et al.. (2014). Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer. Molecular Cancer. 13(1). 225–225. 68 indexed citations
14.
Ye, Lei, Wei‐Dong Du, Marion E. Schneider, et al.. (2013). Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case–control study in China. Medical Oncology. 30(3). 658–658. 13 indexed citations
15.
Wang, Fang, Yanfeng Zou, Qiang Wu, et al.. (2011). Expression of COX-2 and Bcl-2 in primary fallopian tube carcinoma: correlations with clinicopathologic features. Folia Histochemica et Cytobiologica. 49(3). 389–397. 3 indexed citations
16.
Li, Xun & Jifeng Wu. (2010). Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs). Recent Patents on Anti-Cancer Drug Discovery. 5(2). 109–141. 44 indexed citations
17.
Li, Xun, et al.. (2009). Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part II). Bioorganic & Medicinal Chemistry. 17(8). 3061–3071. 15 indexed citations
18.
Li, Xun, Junli Wang, Jinpei Li, et al.. (2009). Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part I). Bioorganic & Medicinal Chemistry. 17(8). 3053–3060. 12 indexed citations
19.
Li, Xun, Hongyu Yuan, Jifeng Wu, et al.. (2008). Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance. Current Medicinal Chemistry. 15(5). 470–476. 53 indexed citations
20.
Wu, Jifeng, S. Furusawa, Shinya Nakano, et al.. (1996). Reversal of multidrug resistance by tacrolimus hydrate.. PubMed. 18(10). 651–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunita Bhagat Breakdown of academic impact, for papers by Susan M. Pullen Breakdown of academic impact, for papers by Yoshihiro Morinaga Breakdown of academic impact, for papers by Darren McKerrecher Breakdown of academic impact, for papers by Takayuki Kudoh Breakdown of academic impact, for papers by Seojeong Park Breakdown of academic impact, for papers by Yuanyuan An Breakdown of academic impact, for papers by Ekaterina Yu. Rybalkina Breakdown of academic impact, for papers by Shanhe Li
Rankless by CCL
2026